Other Slow-Growing Nontuberculous Mycobacteria
- 23 December 2016
- journal article
- review article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 4 (6), 767-776
- https://doi.org/10.1128/microbiolspec.tnmi7-0012-2016
Abstract
The list of clinically important slow-growing nontuberculous mycobacteria (NTM) continues to expand as new species are identified and older ones are found to be pathogenic. Based on pigment production, the strains may be classified as photochromogenic, scotochromogenic, or unpigmented. Some of these organisms are not newly discovered but have heretofore been considered virtually nonpathogenic. Previously, many were regarded as contaminants when isolated from clinical specimens. Ubiquitous in nature, many NTM have been isolated from groundwater or tap water, soil, house dust, domestic and wild animals, and birds. Most infections result from inhalation or direct inoculation from environmental sources. They are not spread from person to person. The infections may be localized or disseminated. In most cases, the optimal regimen or duration of therapy has not been firmly established. The results of in vitro susceptibility testing may be used to select a therapeutic regimen. Many experts recommend clarithromycin with companion drugs such as rifampin and ethambutol for most, but not all, slowly growing species. Aminoglycosides, clofazimine, fluoroquinolones, linezolid, pyrazinamide, or trimethoprim-sulfamethoxazole also may be effective against some strains. Immunocompetent patients with clinically significant infections with NTM usually should receive 18 to 24 months of therapy. Infected immunocompromised patients, particularly those with disseminated infection, probably should receive therapy as long as their immune systems remain impaired. Some of the species discussed include Mycobacterium alsiense , M. celatum , M. gordonae , M. haemophilum , M. kyorinense , M. malmoense , M. simiae complex, M. szulgai , M. terrae complex, M. ulcerans , and M. xenopi .Keywords
This publication has 86 references indexed in Scilit:
- First Case of Mycobacterium longobardum InfectionAnnals of Laboratory Medicine, 2013
- First Isolation of Mycobacterium kyorinense from Clinical Specimens in BrazilJournal of Clinical Microbiology, 2012
- Clinical Manifestations, Diagnosis, and Treatment of Mycobacterium haemophilum InfectionsClinical Microbiology Reviews, 2011
- Immunosuppressive Signature of CutaneousMycobacterium ulceransInfection in the Peripheral Blood of Patients with Buruli Ulcer DiseaseThe Journal of Infectious Diseases, 2009
- Nontuberculous Mycobacteria Infections and Anti–Tumor Necrosis Factor-α TherapyEmerging Infectious Diseases, 2009
- Extrapulmonary Infections Associated with Nontuberculous Mycobacteria in Immunocompetent PersonsEmerging Infectious Diseases, 2009
- Rapid Identification of Mycobacterium tuberculosis and Nontuberculous Mycobacteria by Multiplex, Real-Time PCRJournal of Clinical Microbiology, 2009
- Mycobacterium haemophilumand Lymphadenitis in Immunocompetent Children, IsraelEmerging Infectious Diseases, 2008
- Mycobacterium xenopiClinical Relevance and Determinants, the NetherlandsEmerging Infectious Diseases, 2008
- Mycobacterium alsiense , a Novel, Slowly Growing Species Isolated from Two Patients with Pulmonary DiseaseJournal of Clinical Microbiology, 2007